Human IgG1 (L234A/L235A), kappa Isotype Control Antibody (HyHEL-10), FITC from ProteoGenix; catalogue ARO-A23186; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Human IgG1 (L234A/L235A), kappa Isotype Control Antibody (HyHEL-10), FITC is a monoclonal antibody that specifically binds to the kappa light chain of human immunoglobulin G1 (IgG1). This antibody has been engineered to contain two amino acid mutations (L234A/L235A) that enhance its binding affinity and specificity.
This antibody is commonly used as an isotype control in flow cytometry experiments to distinguish between specific and non-specific binding of antibodies. It can also be used in western blotting and immunohistochemistry applications to ensure the specificity of target antibody binding.
In flow cytometry experiments, Human IgG1 (L234A/L235A), kappa Isotype Control Antibody (HyHEL-10), FITC is used as a negative control to assess the background fluorescence of cells and to determine the appropriate gating strategy. It is also used to confirm the specificity of target antibody binding by comparing the signal intensity between the isotype control and the target antibody.
In western blotting, this antibody is used as a negative control to ensure that the observed bands are specific to the target protein and not due to non-specific binding. It can also be used in immunohistochemistry to confirm the specificity of target antibody binding and to assess the level of non-specific background staining.
This Human IgG1 (L234A/L235A), kappa Isotype Control Antibody (HyHEL-10), FITC is a highly specific and sensitive tool for flow cytometry, western blotting, and immunohistochemistry experiments. Its enhanced binding affinity and specificity make it an ideal choice for researchers looking to accurately distinguish between specific and non-specific antibody binding.
To summarize, Human IgG1 (L234A/L235A), kappa Isotype Control Antibody (HyHEL-10), FITC is a monoclonal antibody with two amino acid mutations that enhance its binding affinity and specificity for the kappa light chain of human IgG1. It is commonly used as an isotype control in flow cytometry, western blotting, and immunohistochemistry experiments to ensure the specificity of target antibody binding. This antibody is a valuable tool for researchers looking to accurately assess and control for non-specific binding in their experiments.
ProteoGenix catalogue number ARO-A23186. For research use only.
Target: Human IgG1 (L234A /L235A), kappa; Clonality: Monoclonal Antibody; Applications: Flow Cyt.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human IgG1 (L234A /L235A), kappa |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
